Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Buddha Burning Energy: Currently not yet engaged in helium-related business.
17/03/2026
On March 17th, Buddha Renewable Energy stated on the interactive platform that the company currently does not engage in any business related to helium gas.
Latest
3 m ago
Sunac China: It is expected that the company's net loss attributable to owners will be between 12 billion to 13 billion yuan by 2025.
3 m ago
Sunac China: Net loss significantly reduced year-on-year.
4 m ago
Beijing launches "Clear Skies and Bright Future AI for Good" special campaign to focus on rectifying five types of network chaos in the field of AI.
4 m ago
Parker New Materials: Net profit in 2025 is 252 million yuan, a year-on-year decrease of 4.37%
5 m ago
According to the AI Fast News of Every Economics, Open Source Securities released a research report on March 17th, giving Punong Medical (920069.SH) a "hold" rating. The reasons for the rating mainly include: 1) Punong Medical: The insulin pen needle "Little Giant" is scarce, developing minimally invasive intervention in the second curve; 2) Industry: The diabetes injection market is stable and growing, and the extension of new businesses in the puncture instrument scene; 3) Company highlights: leading market share, strong technology, good customers, with a comparable company PE 2024 average of 53X. (Everyday Economic News)
See all latest